Genetic testing promises to put the ability to decide about our life choices in our hands, as well as help solve crucial health problems by preventing the insurgence of diseases. But what happens when these exams are managed by private companies in a free market? Public communication and marketing have proven to be crucial battlefields on which companies companies need to engage in order to emerge. This issue of JCOM tries to shed some light on the communication and marketing practices used by private companies that sell direct-to-consumer genetic testing, from single genetic mutations to whole genome sequencing.
|Titolo:||Know your genes. The marketing of direct-to-consumer genetic testing|
|Data di pubblicazione:||2011|
|Numero di Articolo:||C01|
|Appare nelle tipologie:||1.1 Journal article|